SECOND SIGHT MED PRODS INC - COM NEW (EYES) Institutional Ownership

CUSIP: 81362J209

13F Institutional Holders and Ownership History from Q4 2019 to Q3 2022

Type / Class
Equity / COM NEW
Symbol
EYES
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP 81362J209?
CUSIP 81362J209 identifies EYES - SECOND SIGHT MED PRODS INC - COM NEW in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Institutional Holders of SECOND SIGHT MED PRODS INC - COM NEW (EYES) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2022 Q3 0 $0 -$4,458,000 0
2022 Q2 2,079,661 $4,221,000 -$838,864 $2.03 27
2022 Q1 2,737,149 $3,911,000 -$1,323,286 $1.43 22
2021 Q4 3,575,574 $5,826,000 +$530,657 $1.63 26
2021 Q3 2,789,461 $8,894,000 +$889,921 $3.19 36
2021 Q2 55,009 $269,000 -$206,000 $4.00 8
2021 Q1 2,211,599 $17,838,000 +$13,675,830 $8.00 22
2020 Q4 683,815 $1,277,000 +$696,711 $1.86 15
2020 Q3 377,851 $325,000 +$78,796 $0.86 12
2020 Q2 275,025 $269,000 -$27,187 $0.98 12
2020 Q1 300,958 $301,000 +$268,000 $1.00 11
2019 Q4 45,182 $33,000 +$32,000 $0.74 3